FDA Panel To Review Pfizer Inc. (Jobs) HIV Drug

WASHINGTON (AP) -- A Food and Drug Administration panel in April will review a Pfizer HIV therapy that, if approved, would be the first in a new class of drugs to treat the virus that causes AIDS.

>>> Discuss This Story